Evidence map›Paper›PMID 27749529›Full record

SynthesisMedicine2016

Impact of the conversation map tools in patients with type 2 diabetes mellitus: A PRISMA-compliant meta-analysis of randomized controlled trials.

Qing Yang, Ping Fang

Abstract readMeta-AnalysisReview
In one paragraph

Synthesis in Medicine, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update.Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists · 2022
    Guideline
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Qing YangDepartment of Endocrinology Out-patient Department, ZhuJiang Hospital of Southern Medical University, Guangzhou, China.
Ping Fang

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundDiabetes is one of the leading causes of morbidity and mortality worldwide, and type 2 diabetes is the most common type accounting for 90% of all diabetes cases. Health education is considered as the first choice to control blood glucose levels. We conducted a meta-analysis to assess the effect of health education tool "Conversation Map" in diabetes patients to control blood glucose.

methodsWe searched PubMed, Embase, Cochrane Central Register of Controlled Trials, China Knowledge Resource Integrated Database, and China Science Periodical Database up to December, 2015. We assessed the results using the inverse variance method to pool diabetes relative indicators, and assessed the heterogeneity of the results using I-square.

resultsWe collected 22 trials in our meta-analysis, which included 3360 patients. The results showed that the fasting blood-glucose level was significantly reduced in the type 2 diabetes group patients educated with "Conversation Map" when compared to their respective control groups (weighted mean difference [WMD]: -2.23, 95% confidence interval [CI]: -2.70 to -1.76, P < 0.001). Also a significant reduction of 2-hour postprandial blood glucose (WMD: -1.59, 95% CI: -2.27 to -0.92, P < 0.001) and Hemoglobin A1C levels (WMD: -0.63, 95% CI: -1.08 to -0.17, P < 0.001) was also observed when compared to the control groups.

conclusionConversation Map is an effective health education tool for type 2 diabetes, and significantly reduced patients' blood glucose related index.

Indexed as

Patient Education as TopicSelf CareDiabetes Mellitus, Type 2HumansRandomized Controlled Trials as Topic

Identifiers

PMID27749529
PMCPMC5059031

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.